NGFR P210 Citations (3)

Originally described in: The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl.
He Y, Wertheim JA, Xu L, Miller JP, Karnell FG, Choi JK, Ren R, Pear WS. Blood. 2002 Apr 15;99(8):2957-68. PubMed Journal

---

Articles Citing NGFR P210

Articles
Extracellular matrix stiffness causes systematic variations in proliferation and chemosensitivity in myeloid leukemias. Shin JW, Mooney DJ. Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12126-12131. Epub 2016 Oct 10. PubMed
Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo. Wahiduzzaman M, Ota A, Karnan S, Hanamura I, Mizuno S, Kanasugi J, Rahman ML, Hyodo T, Konishi H, Tsuzuki S, Takami A, Hosokawa Y. Cancer Lett. 2018 Oct 1;433:117-130. doi: 10.1016/j.canlet.2018.06.027. Epub 2018 Jun 23. PubMed
A generalized strategy to kill leukemic cells by targeting the regulatory systems governing mitochondrial membrane potential. Liu T, Zhou JH, Gong Y, Zhang Y, Ma Y, Zhang X, Minhajuddin M, Song W, Zhuang Z, Vujovic A, Lu Y, Jia A, Guo R, Ren R, Zhou L, Xiong Y, Huang L, Du X, Zhao TJ, Li P, Jordan CT, Ye H. Cell Rep. 2025 Nov 25;44(11):116496. doi: 10.1016/j.celrep.2025.116496. Epub 2025 Oct 29. PubMed

If you have published an article using this material, please email us at to have your article added to this page.